
The Federal Trade Commission’s antitrust lawsuit against Altria Group Inc. and Juul Labs focuses largely on a noncompete agreement in which the tobacco giant pledged to take its e-cigarettes off the market, reported The Wall Street Journal.
That agreement, according to the agency’s administrative complaint, was the linchpin of a December 2018 deal in which Juul agreed to sell Altria a 35% stake for $12.8 billion.
The FTC, which is suing to unwind Altria’s stake, released a redacted version of its complaint on Friday that describes secret negotiations that led to the blockbuster deal. By securing Altria’s exit from the e-cigarette market, the complaint says, the deal illegally restrained competition.
The Marlboro maker has said its investment doesn’t harm competition and that the company will “vigorously defend” it. A Juul spokesman Friday said the company disagrees with the allegations “and will respond through the appropriate administrative process.”
When sales of Juul’s sleek vaporizer surged in 2017, Altria’s cigarette sales had been declining steadily for years, and the Marlboro maker had yet to reach its goal of developing a market-leading e-cigarette. Juul’s rise presented the tobacco giant with a threat on two fronts: grabbing up market share in the growing e-cigarette market and plunging traditional cigarettes into a steeper decline.
Altria began to make overtures to the e-cigarette maker. The company first tried to buy Juul outright in late 2017 or early 2018, The Wall Street Journal has previously reported. That approach was rebuffed, but talks continued.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas